Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy
H.P. ACTHar gel is a preparation of melanocortin peptides that has been used to treat resistant forms of nephrotic syndrome. To determine whether combination therapy with ACTHar gel and tacrolimus reduces proteinuria and stabilizes renal function, we conducted a prospective, open-label trial in pati...
Main Authors: | James Tumlin, Claude Galphin, Raul Santos, Brad Rovin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Kidney International Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024917301481 |
Similar Items
-
Diabetic Glomerulopathy: Pathogenesis and Management
by: Schmidt Susanne, et al.
Published: (2000-01-01) -
COVID-19–Associated Collapsing Focal Segmental Glomerulosclerosis: A Report of 2 Cases
by: Yuvraj Sharma, et al.
Published: (2020-07-01) -
A case of focal segmental glomerulosclerosis in an adult patient with hypogammaglobulinemia superimposed on membranoproliferative glomerulonephritis in childhood
by: Tsuji Kenji, et al.
Published: (2012-06-01) -
Focal Segmental Glomerulosclerosis: A Single Center Experience
by: Yavuz Ayar, et al.
Published: (2016-09-01) -
Collapsing glomerulopathy superimposed on diabetic nephropathy
by: Praveen Kumar Etta, et al.
Published: (2019-01-01)